MTBC Secures $5MM Credit Facility with Silicon Valley Bank

MTBC, a provider of cloud-based healthcare IT solutions, entered into a $5 million secured line of credit to support growth initiatives with Silicon Valley Bank.

Silicon Valley Bank Provides $10MM Sophiris Bio Facility

Silicon Valley Bank provided $10 million across two term loans to late-stage clinical biopharmaceutical company Sophiris Bio.

SVB Provides $21MM Term Loan Facility to Selecta Biosciences

Selecta Biosciences entered into a term loan facility for up to $21 million with Silicon Valley Bank, which will be used partly to repay its existing term loan facility with Oxford Finance as agent.

Silicon Valley Bank Closes $30MM Facility for Radisys

Radisys closed on an amended $30 million credit facility with Silicon Valley Bank as administrative agent.

Silicon Valley Bank Provides $1MM Facility to FSLogix

FSLogix closed a $1 million debt facility from Silicon Valley Bank, a working capital line of credit for up to $1 million that will be used for general corporate purposes and to support growth.

Silicon Valley Bank Provides $13MM iCAD Facility

iCAD, a provider of advanced image analysis, workflow solutions and radiation therapy for early treatment of cancer, secured a credit facility in the amount of up to $13 million from Silicon Valley Bank.

Silicon Valley Bank Leads $110MM Donuts Facility

Donuts, which manages a top-level domain name portfolio, closed a $110 million credit facility led by Silicon Valley Bank.

SVB Provides $15MM Term Loan for Gemphire

Gemphire Therapeutics entered into a loan and security agreement with Silicon Valley Bank for a term loan of up to $15 million, subject to funding in up to three tranches.

BMO Agents $350MM Envestnet Facility

Envestnet entered into a second amended and restated credit agreement for up to $350 million opportunities to increase commitments by $55 million with Bank of Montreal as administrative agent.

OrbiMed Provides $100MM Facility to Pharming Group

Dutch pharmaceutical firm Pharming Group replaced its $100 million bridge finance with a $100 million permanent facility agreement. OrbiMed provided both financings.